21.09
-0.05 (-0.24%)
| Previous Close | 21.14 |
| Volume | 524,940 |
| Price / Earnings (Forward) | 18.34 |
| Price / Sales | 1.39 |
| Price / Book | 1.17 |
| 52 Weeks Range |
| Profit Margin | -7.50% |
| Operating Margin (TTM) | -5.36% |
| Diluted EPS (TTM) | -1.02 |
| Quarterly Revenue Growth (YOY) | 3.50% |
| Total Debt/Equity (MRQ) | 75.07% |
| Current Ratio (MRQ) | 1.56 |
| Operating Cash Flow (TTM) | 166.00 M |
| Levered Free Cash Flow (TTM) | 69.00 M |
| Return on Assets (TTM) | 0.61% |
| Return on Equity (TTM) | -5.36% |
News Mood
-
Bausch + Lomb (BLCO) Stock Still Looks Undervalued Despite Its 35% Run
5 days ago, 10:27PM
-
Best Growth Stocks to Buy for November 13th
5 days ago, 1:25AM
-
Best Growth Stocks to Buy for November 11th
11 Nov, 1:44AM
AIStockmoo Score
| Value 30% | 0.0 |
| From our AI Insight report's view of expected return against risk. info | NA |
| Relative Valuation info | NA |
| Implied Growth info | NA |
| Valuation History info | NA |
| Low debt. Weak profitability. Positive cash flow. info | |
| Return on Capital info | NA |
| Timing 30% | 3.6 |
| From our AI technical analysis of the chart. info | NA |
| No clear trend over the past year. Trading near its 52-week high. info | |
| In an uptrend: the price is above its moving averages, and they are rising. It has risen well above them. Volume is heavier on up days. info | |
| Candle Patterns info | NA |
| Above its medium-term trend line. info | |
| Sentiment 20% | 0.7 |
| No recent price targets, so based on how targets have been revised. info | |
| Recent news mostly positive. info | |
| Smart Money 20% | -0.5 |
| Insider Activity info | NA |
| Institutions net -0.28% of shares in their latest 13F filings: 60 holders increased, 35 decreased (quarter to 30 Sep 2026). info | |
| Market and sector conditions are neutral. | |
| Market environment cautious. info | |
| Sector outperforming the market. | |
| The pillars agree, so the score is strengthened. | |
| Not in score | |
| Price is high against its 52-week average. info | |
| Trend up on all three terms. Short-term momentum rising. info | |
| Price is near resistance. info | |
| Final Score | 1.34 |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Instruments & Supplies (US) | Mixed | Mixed |
| Medical Instruments & Supplies (Global) | Mixed | Mixed | |
| Stock | Bausch + Lomb Corporation | Mixed | Bullish |
Similar Stocks
| Stock | Market Cap | DY | P/E (TTM) | P/B |
|---|---|---|---|---|
| BLCO | - | - | - | 1.17 |
| RMD | - | 1.08% | - | 5.66 |
| BDX | - | 2.20% | - | 2.41 |
| WST | - | 0.37% | - | 9.67 |
| ALC | - | 0.49% | - | 1.64 |
| STVN | - | 0.30% | - | 2.39 |
Select this tab to load the latest available analysis.
|
Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space. |
|
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Investment Style | Mid Core |
| % Held by Insiders | 88.13% |
| % Held by Institutions | 10.97% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Caspian Capital Lp | 30 Jun 2026 | 1,999,043 |
| Glenview Capital Management, Llc | 30 Jun 2026 | 1,918,148 |
| Clark Estates Inc/Ny | 30 Sep 2026 | 881,000 |
No data within this time range.
No data within this time range.
Institutions
Institutional ownership: 10.66%
| Positions | Holders | Shares |
|---|---|---|
| Increased | 60 | 5,333,667 |
| Decreased | 35 | 5,694,076 |
| New | 24 | 1,736,083 |
| Sold out | 9 | 2,368,991 |
SEC 13F filings via Nasdaq, latest filings up to 30 Sep 2026. Filings arrive up to 45 days after each quarter.
| Date | Type | Details |
|---|---|---|
| 14 Nov 2026 | Yahoo Finance |
Bausch + Lomb (BLCO) Following Its Rally Is Fair Value Still In Sight
Bausch + Lomb (BLCO) has been drawing attention after recent trading, with the share price last closing at US$21.09. The move sits against a recent pattern of mixed short term and longer term returns. Over the past month, Bausch + Lomb has seen a sharp shift in momentum, with a 31.48% 30 day share… |
| 13 Nov 2026 | Yahoo Finance |
Bausch + Lomb (BLCO) Stock Still Looks Undervalued Despite Its 35% Run
Bausch + Lomb shares have moved higher in recent months, which puts a sharper spotlight on whether the current US$21.09 price lines up with the cash flows the business can realistically generate. After a solid stretch for the stock, the key issue for anyone looking at Bausch + Lomb today is how… |
| 13 Nov 2026 | Yahoo Finance |
Best Growth Stocks to Buy for November 13th
BLCO, VLO, and HAS it to the Zacks Rank #1 (Strong Buy) growth stocks list on November 13, 2026… |
| 11 Nov 2026 | Yahoo Finance |
Best Growth Stocks to Buy for November 11th
BLCO, VLO, and HAS it to the Zacks Rank #1 (Strong Buy) growth stocks list on November 11, 2026… |
| 06 Nov 2026 | Yahoo Finance |
Zacks.com featured highlights include Repsol, Bausch + Lomb, DMC Global, Universal Logistics and Methanex
Repsol, Bausch + Lomb and three other stocks show strong relative price strength, rising earnings estimates and potential for further gains. |
| 05 Nov 2026 | Yahoo Finance |
Are You Looking for a Top Momentum Pick? Why Bausch + Lomb (BLCO) is a Great Choice
Does Bausch + Lomb (BLCO) have what it takes to be a top stock pick for momentum investors? Let's find out. |
| 04 Nov 2026 | Yahoo Finance |
Bausch + Lomb: 3 Key Takeaways for Long-Term Investors
Premium product adoption is lifting margins faster than revenue growth, a sign of pricing power in a competitive market. |
| 04 Nov 2026 | Yahoo Finance |
Why Bausch + Lomb (BLCO) Might be Well Poised for a Surge
Bausch + Lomb (BLCO) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions. |
| 03 Nov 2026 | Yahoo Finance |
BLCO vs. HQY: Which Stock Is the Better Value Option?
BLCO vs. HQY: Which Stock Is the Better Value Option? |
Technical Setup Medium
AI Technical Analysis
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |